Target intelligence / Profile preview

Flavin mononucleotide (FMN)

Target
FMN
Molecular classification
Other
01

Overview

**Flavin mononucleotide (FMN)**, also called riboflavin-5'-phosphate, is a derivative of riboflavin (vitamin B2) produced by phosphorylation via the enzyme flavokinase[4][8]. FMN acts as a **redox-active coenzyme** for a wide variety of oxidoreductase enzymes, participating in key electron transfer steps during metabolic processes such as aerobic respiration and photosynthesis[2][4][6][8]. In mitochondria, FMN serves as the first redox cofactor in respiratory Complex I (NADH:ubiquinone oxidoreductase)[8]. FMN is also a cofactor for biological blue-light photoreceptors. It is found bound to proteins as a non-covalent or covalent prosthetic group, contributing to enzymatic catalysis of both one- and two-electron transfer reactions[4][7]. FMN is not a protein target but an essential **cofactor** and **metabolic intermediate**, not considered a direct therapeutic target, receptor, enzyme, or transporter. It is also used as a food color additive (E101a)[4][3]. --- **Explanation of key fields:** - Flavin mononucleotide is not a protein or a receptor—it is a small molecule coenzyme; thus, while essential in biological function, it is not a therapeutic "target" in the conventional sense. Therefore: - **is_target:** false - **is_incorrect:** true (not a legitimate "target" for typical drug action; likely a misinterpretation or miscategorization) - It has many **aliases** related to its chemical structure or food additive use[3][4]. - It functions as a **cofactor** in numerous biological electron transfer reactions, but does not fall within conventional molecular target **families** like receptor, enzyme, or transporter[2][4][6][8]. - It is central to metabolism and energy production but is not itself a direct marker, therapeutic target, or drug substrate[4][6][8]. - **No approved drugs** are designed to bind or inhibit FMN as a primary target[9]. No biomarker or safety profile information is associated, as it is not used as a target for therapy.

Other names
riboflavin-5'-phosphateriboflavine phosphateriboflavin phosphateflavine mononucleotideflavolflanin
02

Biological functions

oxidation–reduction reactionselectron transfercofactor for oxidoreductasesblue-light photoreceptionDNA repaircellular metabolismenergy production
03

Disease associations

Other

Beyond the preview

Go deeper on Flavin mononucleotide (FMN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Flavin mononucleotide (FMN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call